Provided by Tiger Trade Technology Pte. Ltd.

Ocular Therapeutix

10.90
+0.33003.12%
Post-market: 10.39-0.5115-4.69%17:09 EDT
Volume:2.07M
Turnover:22.33M
Market Cap:2.39B
PE:-7.71
High:11.01
Open:10.58
Low:10.47
Close:10.57
52wk High:16.44
52wk Low:6.23
Shares:218.91M
Float Shares:185.00M
Volume Ratio:1.39
T/O Rate:1.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4140
EPS(LYR):-1.4203
ROE:-72.99%
ROA:-34.95%
PB:4.59
PE(LYR):-7.67

Loading ...

May 22, 2020

Major Issues Report

8-K - Current report
May 21, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 14, 2020

Major Issues Report

8-K - Current report
May 08, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 08, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Apr 28, 2020

Major Issues Report

8-K - Current report
Apr 13, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 25, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Mar 12, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 12, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 03, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Feb 05, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 12, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 12, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 08, 2019

Major Issues Report

Current report, item 2.05